Tempest Therapeutics Inc (NASDAQ: TPST) on Tuesday, plunged -8.14% from the previous trading day, before settling in for the closing price of $0.95. Within the past 52 weeks, TPST’s price has moved between $0.80 and $6.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 29.53%. With a float of $37.04 million, this company’s outstanding shares have now reached $43.64 million.
In an organization with 17 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tempest Therapeutics Inc (TPST) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tempest Therapeutics Inc is 15.13%, while institutional ownership is 5.50%. The most recent insider transaction that took place on Aug 12 ’24, was worth 426,993. Before that another transaction happened on Aug 08 ’24, when Company’s 10% Owner sold 400,000 for $1.35, making the entire transaction worth $540,040. This insider now owns 597,940 shares in total.
Tempest Therapeutics Inc (TPST) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.34 earnings per share (EPS) for the period topping the consensus outlook (set at -0.39) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.53% per share during the next fiscal year.
Tempest Therapeutics Inc (NASDAQ: TPST) Trading Performance Indicators
Tempest Therapeutics Inc (TPST) is currently performing well based on its current performance indicators. A quick ratio of 1.69 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.04 in one year’s time.
Technical Analysis of Tempest Therapeutics Inc (TPST)
Let’s dig in a bit further. During the last 5-days, its volume was 1.34 million. That was inferior than the volume of 2.08 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 53.39%. Additionally, its Average True Range was 0.09.
During the past 100 days, Tempest Therapeutics Inc’s (TPST) raw stochastic average was set at 4.89%, which indicates a significant decrease from 30.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.26% in the past 14 days, which was lower than the 101.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0877, while its 200-day Moving Average is $2.2997. However, in the short run, Tempest Therapeutics Inc’s stock first resistance to watch stands at $0.9530. Second resistance stands at $1.0321. The third major resistance level sits at $1.0743. If the price goes on to break the first support level at $0.8317, it is likely to go to the next support level at $0.7895. The third support level lies at $0.7104 if the price breaches the second support level.
Tempest Therapeutics Inc (NASDAQ: TPST) Key Stats
Market capitalization of the company is 38.14 million based on 43,642K outstanding shares. Right now, sales total 0 K and income totals -29,490 K. The company made 0 K in profit during its latest quarter, and -10,560 K in sales during its previous quarter.
